Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

AAIC 2017 | What do biomarkers mean for the treatment of Alzheimer’s disease?

Liana Apostolova • 17 Aug 2017
AAIC 2017
Alzheimer’s Disease

Liana Apostolova, MD, MS from Indiana University School of Medicine, Indianapolis, IN gives us an overview of how biomarkers can be important in identifying the pathogenesis of Alzheimer’s disease, and explains their value in treating Alzheimer’s patients. This interview was recorded at the 2017 Alzheimer’s Association International Conference (AAIC) in London, UK.

More from Liana Apostolova

Characterizing co-pathologies: a hot topic in the field of Alzheimer's disease
2:18
Characterizing co-pathologies: a hot topic in the field of Alzheimer's disease
Liana Apostolova • 17 Aug 2017
The challenges of diagnosing Alzheimer’s disease
1:50
The challenges of diagnosing Alzheimer’s disease
Liana Apostolova • 17 Aug 2017
New IDEAS: biomarkers in AD patient outcomes
1:09
New IDEAS: biomarkers in AD patient outcomes
Liana Apostolova • 17 Aug 2017
Late and early-onset AD: understanding the differences
2:29
Late and early-onset AD: understanding the differences
Liana Apostolova • 17 Aug 2017

Related Videos

A multimodal model to detect and stage Alzheimer's disease using MRI, acoustic signals, and genetics
10:28
A multimodal model to detect and stage Alzheimer's disease using MRI, acoustic signals, and genetics
Muhammad Umar Khan • 28 Aug 2026
Neuroprotective effects of aortic valve replacement: a propensity score-matched cohort study
3:25
Neuroprotective effects of aortic valve replacement: a propensity score-matched cohort study
Vikash Jaiswal • 26 Aug 2026
What are the biological mechanisms underlying the higher prevalence of AD in women?
1:55
What are the biological mechanisms underlying the higher prevalence of AD in women?
Amber Watts • 14 Jul 2026
MenoCog: risk and protective factors for cognitive function in the menopause transition
2:37
MenoCog: risk and protective factors for cognitive function in the menopause transition
Amber Watts • 14 Jul 2026

Choose your cookie settings

VJDementia uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJDementia is intended for healthcare professionals